Copyright
©The Author(s) 2025.
World J Methodol. Dec 20, 2025; 15(4): 106148
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.106148
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.106148
Table 2 Role of probiotics in inducing remission in Crohn’s disease
Ref. | Type of study | Number (n) | Findings |
Gupta et al[19] | Open label | 4 CD patients. No control group | Improvement in clinical activity |
Schultz et al[20] | DB RCT | Treatment group (n = 5). Control group (n = 6) | No benefits of probiotics |
Fujimori et al[21] | Open label | 10 CD patients. No control group | Decrease in CDAI |
Steed et al[22] | DB RCT | Treatment group (n = 13). Control group (n = 11) | Decrease in CDAI |
- Citation: Singh JP, Aleissa M, Chitragari G, Drelichman ER, Mittal VK, Bhullar JS. Uncovering the role of microbiota and fecal microbiota transplantation in Crohn’s disease: Current advances and future hurdles. World J Methodol 2025; 15(4): 106148
- URL: https://www.wjgnet.com/2222-0682/full/v15/i4/106148.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i4.106148